323 related articles for article (PubMed ID: 22991070)
1. Update on progressive multifocal leukoencephalopathy.
Steiner I; Berger JR
Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Bauer J; Gold R; Adams O; Lassmann H
Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
[TBL] [Abstract][Full Text] [Related]
3. Advances in the management of PML: focus on natalizumab.
Fox R
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S33-7. PubMed ID: 22123933
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy.
Aksamit AJ
Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1374-91. PubMed ID: 23221846
[TBL] [Abstract][Full Text] [Related]
6. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
Front Immunol; 2019; 10():1188. PubMed ID: 31191548
[No Abstract] [Full Text] [Related]
7. Progressive multifocal leukoencephalopathy.
Weissert R
J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.
Shahani L; Shah M; Tavakoli-Tabasi S
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26063110
[TBL] [Abstract][Full Text] [Related]
9. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
[TBL] [Abstract][Full Text] [Related]
10. Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Lambert N; Dauby S; Dive D; Sadzot B; Maquet P
Emerg Infect Dis; 2022 Jan; 28(1):253-6. PubMed ID: 34856110
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Baldwin KJ; Hogg JP
Curr Opin Neurol; 2013 Jun; 26(3):318-23. PubMed ID: 23493158
[TBL] [Abstract][Full Text] [Related]
12. The human JC polyomavirus (JCPyV): virological background and clinical implications.
Hirsch HH; Kardas P; Kranz D; Leboeuf C
APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
[TBL] [Abstract][Full Text] [Related]
13. Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
Blinkenberg M; Sellebjerg F; Leffers AM; Madsen CG; Sørensen PS
Mult Scler; 2013 Aug; 19(9):1226-9. PubMed ID: 23508652
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.
Ferenczy MW; Marshall LJ; Nelson CD; Atwood WJ; Nath A; Khalili K; Major EO
Clin Microbiol Rev; 2012 Jul; 25(3):471-506. PubMed ID: 22763635
[TBL] [Abstract][Full Text] [Related]
16. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
Harypursat V; Zhou Y; Tang S; Chen Y
AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy.
Harrison DM; Newsome SD; Skolasky RL; McArthur JC; Nath A
J Neuroimmunol; 2011 Sep; 238(1-2):81-6. PubMed ID: 21840066
[TBL] [Abstract][Full Text] [Related]
18. Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter.
Dang X; Koralnik IJ
Ann Neurol; 2013 Oct; 74(4):503-5. PubMed ID: 23913509
[No Abstract] [Full Text] [Related]
19. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
20. Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
Calvi A; De Riz M; Pietroboni AM; Ghezzi L; Maltese V; Arighi A; Fumagalli GG; Jacini F; Donelli C; Comi G; Galimberti D; Scarpini E
Immunotherapy; 2014; 6(1):23-8. PubMed ID: 24341880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]